GenSigt will participate to the Ophthalmology Innovation Summit at the Marriott Marquis Chicago on October 25, 2018 on the occasion of the American Academy of Ophthalmology, October 27-30, 2018.

Barrett Katz, MD, Chief Medical Officer, will present the Positive Results from REVERSE Phase III Clinical Trial of GS010 for Treatment of Leber Hereditary Optic Neuropathy (LHON). Details coming soon.